These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 35037475)

  • 1. Differences in cerebral blood flow measurement using arterial spin labeling MRI between patients with moyamoya disease and patients with arteriosclerotic cerebrovascular disease.
    Ueda Y; Tanaka Y; Hara S; Inaji M; Ishii K; Maehara T; Nariai T
    Acta Radiol; 2023 Jan; 64(1):311-319. PubMed ID: 35037475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arterial spin-labeling MR imaging in Moyamoya disease compared with clinical assessments and other MR imaging findings.
    Noguchi T; Kawashima M; Nishihara M; Hirai T; Matsushima T; Irie H
    Eur J Radiol; 2013 Dec; 82(12):e840-7. PubMed ID: 24055185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-Delay Arterial Spin Labeling Provides More Accurate Cerebral Blood Flow Measurements in Moyamoya Patients: A Simultaneous Positron Emission Tomography/MRI Study.
    Fan AP; Guo J; Khalighi MM; Gulaka PK; Shen B; Park JH; Gandhi H; Holley D; Rutledge O; Singh P; Haywood T; Steinberg GK; Chin FT; Zaharchuk G
    Stroke; 2017 Sep; 48(9):2441-2449. PubMed ID: 28765286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Utility of Arterial Transit Time Measurement for Evaluating the Hemodynamic Perfusion State of Patients with Chronic Cerebrovascular Stenosis or Occlusive Disease: Correlative Study between MR Imaging and
    Takeuchi K; Isozaki M; Higashino Y; Kosaka N; Kikuta KI; Ishida S; Kanamoto M; Takei N; Okazawa H; Kimura H
    Magn Reson Med Sci; 2023 Jul; 22(3):289-300. PubMed ID: 35545508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical assessment of cerebral hemodynamics in Moyamoya disease via multiple inversion time arterial spin labeling and dynamic susceptibility contrast-magnetic resonance imaging: A comparative study.
    Qiao PG; Han C; Zuo ZW; Wang YT; Pfeuffer J; Duan L; Qian T; Li GJ
    J Neuroradiol; 2017 Jul; 44(4):273-280. PubMed ID: 28168990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arterial Spin Labeling MRI for Quantitative Assessment of Cerebral Perfusion Before and After Cerebral Revascularization in Children with Moyamoya Disease.
    Ha JY; Choi YH; Lee S; Cho YJ; Cheon JE; Kim IO; Kim WS
    Korean J Radiol; 2019 Jun; 20(6):985-996. PubMed ID: 31132824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying Hypoperfusion in Moyamoya Disease With Arterial Spin Labeling and an [
    Fan AP; Khalighi MM; Guo J; Ishii Y; Rosenberg J; Wardak M; Park JH; Shen B; Holley D; Gandhi H; Haywood T; Singh P; Steinberg GK; Chin FT; Zaharchuk G
    Stroke; 2019 Feb; 50(2):373-380. PubMed ID: 30636572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-Dimensional Arterial Spin Labeling for the Evaluation of the Cerebral Hemodynamics in Ischemic and Hemorrhagic Moyamoya Disease.
    Bian H; Zhang L; Wang J
    Cerebrovasc Dis; 2024; 53(3):307-315. PubMed ID: 37722371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arterial spin-labeling cerebral perfusion changes after revascularization surgery in pediatric moyamoya disease and syndrome.
    Quon JL; Kim LH; Lober RM; Maleki M; Steinberg GK; Yeom KW
    J Neurosurg Pediatr; 2019 Apr; 23(4):486-492. PubMed ID: 30738390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noninvasive Evaluation of CBF and Perfusion Delay of Moyamoya Disease Using Arterial Spin-Labeling MRI with Multiple Postlabeling Delays: Comparison with
    Hara S; Tanaka Y; Ueda Y; Hayashi S; Inaji M; Ishiwata K; Ishii K; Maehara T; Nariai T
    AJNR Am J Neuroradiol; 2017 Apr; 38(4):696-702. PubMed ID: 28209582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can combined high-resolution vessel wall imaging and multiple post-labeling delay 3D pseudo-continuous arterial spin labeling differentiate moyamoya disease from atherosclerotic moyamoya syndrome?
    Guo Y; Dou W; Wang X; Wang X; Mao H; Chen K
    Eur J Radiol; 2023 Dec; 169():111184. PubMed ID: 37931375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arterial spin labeling magnetic resonance imaging at short post-labeling delay reflects cerebral perfusion pressure verified by oxygen-15-positron emission tomography in cerebrovascular steno-occlusive disease.
    Itagaki H; Kokubo Y; Kawanami K; Sato S; Yamada Y; Sato S; Sonoda Y
    Acta Radiol; 2021 Feb; 62(2):225-233. PubMed ID: 32295388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-contrast hemodynamic imaging of Moyamoya disease with MR fingerprinting ASL: A feasibility study.
    Su P; Liu P; Pinho MC; Thomas BP; Qiao Y; Huang J; Welch BG; Lu H
    Magn Reson Imaging; 2022 May; 88():116-122. PubMed ID: 35183659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arterial transit artifacts observed by arterial spin labeling in Moyamoya disease.
    Ukai R; Mikami T; Nagahama H; Wanibuchi M; Akiyama Y; Miyata K; Mikuni N
    J Stroke Cerebrovasc Dis; 2020 Sep; 29(9):105058. PubMed ID: 32807463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of delayed transit time on arterial spin labeling: correlation with dynamic susceptibility contrast perfusion magnetic resonance in moyamoya disease.
    Yun TJ; Sohn CH; Han MH; Kang HS; Kim JE; Yoon BW; Paeng JC; Choi SH; Kim JH; Song IC; Chang KH
    Invest Radiol; 2013 Nov; 48(11):795-802. PubMed ID: 23764569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel application of four-dimensional magnetic resonance angiography using an arterial spin labeling technique for noninvasive diagnosis of Moyamoya disease.
    Uchino H; Ito M; Fujima N; Kazumata K; Yamazaki K; Nakayama N; Kuroda S; Houkin K
    Clin Neurol Neurosurg; 2015 Oct; 137():105-11. PubMed ID: 26185929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arterial spin labeling in patients with chronic cerebral artery steno-occlusive disease: correlation with (15)O-PET.
    Kamano H; Yoshiura T; Hiwatashi A; Abe K; Togao O; Yamashita K; Honda H
    Acta Radiol; 2013 Feb; 54(1):99-106. PubMed ID: 23091237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of MR mTI-ASL and DSC-PWI in evaluating cerebral hemodynamics of patients with Moyamoya disease.
    Zhang J; Xia C; Liu Y; Qian W; Peng W; Liu K; Li L; Zhao F; Li Z
    Medicine (Baltimore); 2018 Oct; 97(41):e12768. PubMed ID: 30313089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrovascular reactivity measurements using simultaneous
    Zhao MY; Fan AP; Chen DY; Sokolska MJ; Guo J; Ishii Y; Shin DD; Khalighi MM; Holley D; Halbert K; Otte A; Williams B; Rostami T; Park JH; Shen B; Zaharchuk G
    Neuroimage; 2021 Jun; 233():117955. PubMed ID: 33716155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-resolution combined arterial spin labeling MR for identifying cerebral arterial stenosis induced by moyamoya disease or atherosclerosis.
    Ya J; Zhou D; Ding J; Ding Y; Ji X; Yang Q; Meng R
    Ann Transl Med; 2020 Feb; 8(4):87. PubMed ID: 32175380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.